15 Jun 2015 | 09:41 am |
International law firm Pinsent Masons has advised home builder Cairn Homes on its initial public offering (IPO) on the main market of the London Stock Exchange, raising €385 million and with an initial market capitalisation of €430 million.
Cairn is the first Irish homebuilder to list for more than 20 years and the funds raised will be used to fund development of several sites the company has acquired in Dublin and Galway and to acquire and develop further sites.
Corporate partner Andrew Black and senior associate Chrissy Findlay led the Pinsent Masons team advising on the transaction, with assistance from Gareth Edwards, Louise Wolfson, James Kaye and Costa Smith.
Commenting on the deal, Andrew Black said:
"We are delighted to have helped Cairn achieve this IPO, which had many novel features and will give them the firepower to build a land bank in an area with high demand for new homes in a strongly recovering economy.”
Key Contacts
Multinational law firm Pinsent Masons has advised the Supervisory Board of Telefónica Deutschland on the delisting tender offer of Telefónica Local Services GmbH, a subsidiary of Telefónica, S.A.
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.
Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.
Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.
Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]